Figure 2
Figure 2. Secondary expansion of polyclonally activated Treg cells after transfer into the allogeneic host sustains a beneficial Treg cell/Tconv cell ratio. (A) CFSE dilution among CD4+ CD90.1+ Foxp3+ and Foxp3− donor T cells isolated from spleen (Spl) or mesenteric LNs (mLN) 3 days after transplantation into lethally irradiated BALB/c hosts. The figures represent the percentages of cells per quadrant. (B) Frequencies of Foxp3+ cells among CD4+ CD90.1+ donor T cells 3 and 6 days after transplantation. The bars indicate means ± SD of 3 mice per group. pLN indicates peripheral LNs. The data are representative for 5 experiments with similar results. (C) Direct comparison of suppressive activity of Treg cells from PBS- or CD28-SA–treated donors in vivo. Either 2.5 (n = 11) or 1.25 × 105 CD4+ CD25+ Treg cells (n = 11) from PBS- or CD28-SA–treated mice were transplanted into lethally irradiated BALB/c recipients together with 2.5 × 105 CD4+ CD25− cells from mice treated with PBS and 107 C57BL/6 TCD BM cells. Control mice received only TCD BM cells (n = 10) or TCD BM cells together with CD4+ CD25− cells (PBS; n = 10). Data from 2 experiments were pooled. P values refer to the comparison of recipients of Treg cells from either PBS- or CD28-SA–treated donors.

Secondary expansion of polyclonally activated Treg cells after transfer into the allogeneic host sustains a beneficial Treg cell/Tconv cell ratio. (A) CFSE dilution among CD4+ CD90.1+ Foxp3+ and Foxp3 donor T cells isolated from spleen (Spl) or mesenteric LNs (mLN) 3 days after transplantation into lethally irradiated BALB/c hosts. The figures represent the percentages of cells per quadrant. (B) Frequencies of Foxp3+ cells among CD4+ CD90.1+ donor T cells 3 and 6 days after transplantation. The bars indicate means ± SD of 3 mice per group. pLN indicates peripheral LNs. The data are representative for 5 experiments with similar results. (C) Direct comparison of suppressive activity of Treg cells from PBS- or CD28-SA–treated donors in vivo. Either 2.5 (n = 11) or 1.25 × 105 CD4+ CD25+ Treg cells (n = 11) from PBS- or CD28-SA–treated mice were transplanted into lethally irradiated BALB/c recipients together with 2.5 × 105 CD4+ CD25 cells from mice treated with PBS and 107 C57BL/6 TCD BM cells. Control mice received only TCD BM cells (n = 10) or TCD BM cells together with CD4+ CD25 cells (PBS; n = 10). Data from 2 experiments were pooled. P values refer to the comparison of recipients of Treg cells from either PBS- or CD28-SA–treated donors.

Close Modal

or Create an Account

Close Modal
Close Modal